Skip to Content

WPI 3355 (Nateglinide 120 mg)

Pill with imprint WPI 3355 is Pink, Capsule-shape and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc..

Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3355

Nateglinide

Imprint:
WPI 3355
Strength:
120 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Meglitinides
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories Inc.
Inactive Ingredients:
silicon dioxide colloidal
fumaric acid
hypromellose 2910 (3 mPa.s)
lactose monohydrate
magnesium stearate
polysorbate 80
sodium starch glycolate type A potato
corn starch
titanium dioxide
hypromellose 2910 (6 mPa.s)
FD&C Red No. 40
aluminum oxide
ferric oxide red
ferric oxide black
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide